These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2172462)

  • 1. Some characteristics of a peptidyl dipeptidase (kininase II) from rat CSF: differential effects of NaCl on the sequential degradation steps of bradykinin.
    Yoshida T; Nosaka S
    J Neurochem; 1990 Dec; 55(6):1861-9. PubMed ID: 2172462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of placental proteases in bradykinin (BK) degradation.
    Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
    Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.
    Jaspard E; Wei L; Alhenc-Gelas F
    J Biol Chem; 1993 May; 268(13):9496-503. PubMed ID: 7683654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone.
    Skidgel RA; Erdös EG
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1025-9. PubMed ID: 2983326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin metabolism pathway in the rat pulmonary circulation.
    Pesquero JB; Jubilut GN; Lindsey CJ; Paiva AC
    J Hypertens; 1992 Dec; 10(12):1471-8. PubMed ID: 1363432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.
    Ahmad M; Zeitlin IJ; Parratt JR; Pitt AR
    Arch Pharm Res; 2006 Mar; 29(3):241-8. PubMed ID: 16596998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.
    Oliveira EB; Souza LL; Sivieri DO; Bispo-da-Silva LB; Pereira HJ; Costa-Neto CM; Sousa MV; Salgado MC
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3550-7. PubMed ID: 17906107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
    J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).
    Inokuchi J; Nagamatsu A
    Biochim Biophys Acta; 1981 Dec; 662(2):300-7. PubMed ID: 6274413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
    Erşahin C; Simmons WH
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II.
    Togo J; Burch RM; DeHaas CJ; Connor JR; Steranka LR
    Peptides; 1989; 10(1):109-12. PubMed ID: 2546127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular reactivity to angiotensin and angiotensin-converting enzyme activity in cerebrospinal fluid.
    Whalley ET; Wahl M
    Brain Res; 1988 Jan; 438(1-2):1-7. PubMed ID: 2830937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema: a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors.
    Davin L; Marechal P; Lancellotti P; Martinez C; Pierard L; Radermecker R
    Acta Cardiol; 2019 Aug; 74(4):277-281. PubMed ID: 30328786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1989 Mar; 38(6):993-1000. PubMed ID: 2539165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.